Status:
UNKNOWN
The Use of 3D Surface Imaging in the Objective Assessment of Breast Conserving Therapy
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Conditions:
Breast Cancer
Eligibility:
FEMALE
Brief Summary
3D surface imaging has been used in the objective evaluation of cosmetic outcome of oncoplastic procedures such as breast reconstruction and lipofilling, however there is only one article published re...
Detailed Description
BCT is the most common breast surgical oncological procedure performed with approximately 28,500 patients undergoing this operation every year. In breast cancer surgery, the primary aim of removing th...
Eligibility Criteria
Inclusion
- Female patients
- No age limit
- underwent unilateral breast conserving surgery at The Royal Marsden NHS Foundation Trust (RMH)
- underwent adjuvant whole breast radiotherapy at RMH
- attending for their annual surveillance mammogram
- between one and five and half years after surgery (rounded to nearest whole year)
Exclusion
- undergone surgery to the contralateral breast (breast conserving surgery, symmetrisation or mastectomy)
- undergone further surgery to the affected breast subsequent to BCT (eg lipofilling or other reconstruction).
- unable to stand for long enough to have clinical photos (approximately 10 minutes)
- unable to answer the BREAST-Q questionaire (e.g. learning difficulties)
Key Trial Info
Start Date :
April 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 24 2020
Estimated Enrollment :
346 Patients enrolled
Trial Details
Trial ID
NCT02304614
Start Date
April 1 2015
End Date
December 24 2020
Last Update
October 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Royal Marsden NHS Foundation Trust
Sutton, United Kingdom, SM2 5PT